Atlas Trials

Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Clinical trial NCT05509725 · UNKNOWN

Trial details

NCT number
NCT05509725
Sponsor
Lallemand Health Solutions
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
IBS - Irritable Bowel Syndrome
Start date
2022-08-11
Primary completion
2024-11-01
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.